Mucus D Tablet, Multilayer, Extended Release
Product Images NDC 79481-0119

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Mucus D (NDC 79481-0119). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meijer, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Mucus-d-image (Image 01)

Mucus-d-image (Image 01)
Mucus-D extended-release bi-layer tablets contain guaifenesin 1200 mg and pseudoephedrine hydrochloride 120 mg. The oral tablets are marketed by Meijer, Inc. The packaging highlights the 12-hour nasal decongestant and expectorant benefits, with 24 tablets per package. The label includes drug facts, usage directions, warnings, and an image showing the tablet's bi-layer design.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.